Glenmark receives ANDA approval for Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) EP News Bureau Aug 23, 2019 A generic version of Faslodex Injection, 250 mg/5 mL (50 mg/mL), of AstraZeneca Pharmaceuticals